Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Clinical study elucidates mechanism of action of antiplatelet compound E-5510

Feb. 16, 1999

Fibrinogen antagonist does not prevent restenosis after stent implantation in dog model

Feb. 16, 1999

Novel, orally bioavailable anticoagulants discovered at Lilly

Feb. 16, 1999

Abciximab undergoing clinical evaluation in acute ischemic stroke

Feb. 9, 1999

Clot-dissolving drug significantly improves disability outcome in phase III stroke trial

Feb. 9, 1999

Roberts and Yuhan enter distribution agreement for Agrylin in Korea

Feb. 3, 1999

Otsuka discovers new platelet aggregation inhibitors and antithrombotic agents

Feb. 1, 1999

U.K. launch announced for hemophilia B treatment

Jan. 29, 1999

Searle drops development of gpIIb/IIIa receptor antagonists

Jan. 25, 1999

Potent heterocyclic antithrombotic agents discovered by Lilly

Jan. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...